Your browser doesn't support javascript.
loading
Progress in immunotherapy targeting PD-1/PD-L1 for lung cancer / 中国实用内科杂志
Chinese Journal of Practical Internal Medicine ; (12): 403-406, 2019.
Artículo en Chino | WPRIM | ID: wpr-816033
ABSTRACT
Lung cancer is the leading cause of cancer-related mortality with high malignancy. In recent years, a major breakthrough has been made in immunotherapy targeting PD-1/PD-L1 for lung cancer, which altered the traditional therapeutic pattern of lung cancer and heralded the dawn of the new immune era. This paper reviewed the application of immune checkpoint blockers in the subtypes of lung cancer, immune-related adverse events, the selection of potential biomarkers, and the exploration of resistance mechanisms.

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Idioma: Chino Revista: Chinese Journal of Practical Internal Medicine Año: 2019 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Idioma: Chino Revista: Chinese Journal of Practical Internal Medicine Año: 2019 Tipo del documento: Artículo